Przemyslaw Borek, MD
Clinical Cardiac Electrophysiology · Nashville, TNNPI 1265606255
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Medical Device Business Services, Inc. at 57.3% of the total. Reporting peaked in 2023 at $10,374 and has fallen 76.3% since, to $2,458 in 2025.
Across 279 payments — averaging $103.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$17K
- Medtronic$6K
- Boston Scientific$2K
- Abbott$1K
- Biosense Webster, Inc.$809
- E.r. Squibb & Sons, L.L.C.$479
- plus $1K from 17 others
Across 77 payments — averaging $3099.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$227K
- Boston Scientific$12K
What the payments were for
- Consulting fees$16,50057%
- Travel & lodging$2,74910%
- Food & beverage$9,57233%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 14 | $16,500 |
| Medtronic(3 entities) | 65 | $6,134 |
| Boston Scientific | 59 | $2,484 |
| Abbott | 24 | $1,046 |
| Biosense Webster, Inc. | 37 | $809 |
| E.r. Squibb & Sons, L.L.C. | 22 | $479 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $232 |
| Pfizer | 11 | $194 |
| Biotronik Inc. | 2 | $156 |
| Sanofi-aventis U.S. LLC | 1 | $123 |
| Alnylam Pharmaceuticals Inc. | 6 | $119 |
| Volta Medical Inc | 1 | $100 |
| Johnson & Johnson | 6 | $88 |
| Shockwave Medical, Inc | 3 | $69 |
| Merck | 5 | $67 |
| Amgen | 4 | $54 |
| Daiichi Sankyo Inc. | 2 | $49 |
| Novartis | 2 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Novo Nordisk | 1 | $21 |
| AstraZeneca | 1 | $17 |
| Altathera Pharmaceuticals LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$15,520
- Carto 3 System$1,236
- EVERA MRI XT DR SURESCAN$1,217
- NA$972
- Micra$744
- AURORA EV-ICD MRI SURESCAN$458
- PulseSelect$350
- Farapulse$293
- RESONATE$237
- ELIQUIS$231
- VIGILANT$216
- ENSITE$173
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$171
- Claria MRI$141
- DIAMONDTEMP BIDIRECTIONAL ABLATION CATHETER$137
- Watchman$123
- Serena$115
- Evera$108
- Attain$107
- GENERAL - THERAPIES$106
How this compares
$28,821 in reported general payments places this provider in the 65th percentile of 82 clinical cardiac electrophysiology providers in Tennessee.
See all clinical cardiac electrophysiology providers in Tennessee →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 373 | $402,506 |
| XareltoRivaroxaban | 153 | $169,586 |
| Dofetilide | 74 | $21,229 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 18 | $2,281 |
| Amiodarone Hcl | 115 | $2,173 |
| Metoprolol Succinate | 96 | $1,274 |
| SotalolSotalol Hcl | 55 | $856 |
| Metoprolol Tartrate | 131 | $854 |
| Flecainide Acetate | 16 | $783 |
| Carvedilol | 57 | $459 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 23 | $378 |
| Amlodipine-ValsartanAmlodipine Besylate/Valsartan | 12 | $307 |
| Spironolactone | 16 | $168 |
| Losartan Potassium | 16 | $150 |
| Amlodipine Besylate | 24 | $136 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $194 | $402,506373 claims |
| Johnson & JohnsonXarelto | $88 | $169,586153 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 82 clinical cardiac electrophysiology providers in Tennessee.
Other clinical cardiac electrophysiology in Nashville
- Stephen FahrigNashville$605K
- Gregory BashianNashville$361K
- William StevensonNashville$172K
- Sandeep DuggalNashville$151K
- Sean WhalenNashville$149K
- Harikrishna TandriNashville$97K
- Robert PickettNashville$95K
- Robert JonesNashville$57K
- Giovanni Davogustto CataldoNashville$42K
- Jonathan GandhiNashville$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.